Cargando…

The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives

A proportion of breast carcinomas develop as a result of a genetic predispostion to the disease. Prior to cloning of the BRCA1 and BRCA2 genes a limited number of studies were carried out to identify specific histopathological characteristics of hereditary breast cancer. These studies are the subjec...

Descripción completa

Detalles Bibliográficos
Autor principal: van de Vijver, Marc J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138507/
https://www.ncbi.nlm.nih.gov/pubmed/11250679
http://dx.doi.org/10.1186/bcr9
_version_ 1782120465523802112
author van de Vijver, Marc J
author_facet van de Vijver, Marc J
author_sort van de Vijver, Marc J
collection PubMed
description A proportion of breast carcinomas develop as a result of a genetic predispostion to the disease. Prior to cloning of the BRCA1 and BRCA2 genes a limited number of studies were carried out to identify specific histopathological characteristics of hereditary breast cancer. These studies are the subject of this review. The main finding was the association of the (atypical) medullary type of breast cancer with a family history; the most important caveat being that medullary breast cancer is found more frequently in young patients. In view of the frequent bilateral occurrence of lobular cancer, this histologic type is also likely to be associated with a predisposing genetic defect. Future investigations will have to test this hypothesis. In addition to mutations in the BRCA1 and BRCA2 genes, there are as yet unidentified genetic defects predisposing to breast cancer development, and histopathology may well help in identifying these genes in the future.
format Text
id pubmed-138507
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1385072003-02-27 The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives van de Vijver, Marc J Breast Cancer Res Review A proportion of breast carcinomas develop as a result of a genetic predispostion to the disease. Prior to cloning of the BRCA1 and BRCA2 genes a limited number of studies were carried out to identify specific histopathological characteristics of hereditary breast cancer. These studies are the subject of this review. The main finding was the association of the (atypical) medullary type of breast cancer with a family history; the most important caveat being that medullary breast cancer is found more frequently in young patients. In view of the frequent bilateral occurrence of lobular cancer, this histologic type is also likely to be associated with a predisposing genetic defect. Future investigations will have to test this hypothesis. In addition to mutations in the BRCA1 and BRCA2 genes, there are as yet unidentified genetic defects predisposing to breast cancer development, and histopathology may well help in identifying these genes in the future. BioMed Central 1999 1999-10-27 /pmc/articles/PMC138507/ /pubmed/11250679 http://dx.doi.org/10.1186/bcr9 Text en Copyright © 1999 Current Science Ltd
spellingShingle Review
van de Vijver, Marc J
The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives
title The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives
title_full The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives
title_fullStr The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives
title_full_unstemmed The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives
title_short The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives
title_sort pathology of familial breast cancer: the pre-brca1/brca2 era - historical perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138507/
https://www.ncbi.nlm.nih.gov/pubmed/11250679
http://dx.doi.org/10.1186/bcr9
work_keys_str_mv AT vandevijvermarcj thepathologyoffamilialbreastcancertheprebrca1brca2erahistoricalperspectives
AT vandevijvermarcj pathologyoffamilialbreastcancertheprebrca1brca2erahistoricalperspectives